207 related articles for article (PubMed ID: 11319375)
1. [Management of erysipelas].
Granier F
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):429-42. PubMed ID: 11319375
[TBL] [Abstract][Full Text] [Related]
2. [Erysipelas and necrotizing fasciitis: management (short text). Consensus conference. French Society of Dermatology].
Ann Med Interne (Paris); 2000 Oct; 151(6):465-70. PubMed ID: 11104925
[No Abstract] [Full Text] [Related]
3. [Erysipelas].
Caetano M; Amorin I
Acta Med Port; 2005; 18(5):385-93. PubMed ID: 16611543
[TBL] [Abstract][Full Text] [Related]
4. [Should NSAID/corticoids be considered when treating erysipelas?].
Jaussaud R; Kaeppler E; Strady C; Beguinot I; Waldner A; Rémy G
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):348-51. PubMed ID: 11319363
[TBL] [Abstract][Full Text] [Related]
5. [Consensus conference. Erysipelas and necrotizing fasciitis. Short text].
J Mal Vasc; 2000 Oct; 25(4):270-5. PubMed ID: 11060422
[No Abstract] [Full Text] [Related]
6. [Primary and secondary prevention for erysipelas].
Becq-Giraudon B
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367
[TBL] [Abstract][Full Text] [Related]
7. [Primary and secondary hospitalization criteria].
Bernard P
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):363-7. PubMed ID: 11319366
[TBL] [Abstract][Full Text] [Related]
8. [Erysipelas: epidemiologic, clinical and therapeutic data].
Jeune R
Ann Dermatol Venereol; 1991; 118(8):545-6. PubMed ID: 1952693
[No Abstract] [Full Text] [Related]
9. [Complex methods of treatment and prevention of erysipelas].
Khlestkov AA; Raskovalov MG; Vyguzov AP
Klin Med (Mosk); 1976 Jun; 54(6):18-21. PubMed ID: 787663
[No Abstract] [Full Text] [Related]
10. [Erysipelas. Retrospective study of 647 patients].
Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
[TBL] [Abstract][Full Text] [Related]
11. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent erysipelas].
Dangoisse C; Ledoux M
Rev Med Brux; 1991 Sep; 12(7):253-6. PubMed ID: 1925175
[TBL] [Abstract][Full Text] [Related]
13. Recurrent erysipelas: 47 cases.
Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
[TBL] [Abstract][Full Text] [Related]
14. [Erysipelas and lymphedema].
Herpertz U
Fortschr Med; 1998 Apr; 116(12):36-40. PubMed ID: 9622973
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
Vignes S; Dupuy A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic use in patients with erysipelas: a retrospective study.
Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
[TBL] [Abstract][Full Text] [Related]
17. [Hospitalization criteria for erysipelas: prospective study in 145 cases].
Jégou J; Hansmann Y; Chalot F; Roger M; Faivre B; Granel F; Scrivener Y; Cairey-Remonnay S; Bernard P
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):375-9. PubMed ID: 12055535
[TBL] [Abstract][Full Text] [Related]
18. Erysipelas: not always innocent.
Ligtenberg G; Blankestijn PJ; Koomans HA
Neth J Med; 1993 Oct; 43(3-4):179-82. PubMed ID: 8302397
[TBL] [Abstract][Full Text] [Related]
19. [Acute inflammation: when and how to treat?].
Schaeffer A; el Murr T
Rev Prat; 2003 Mar; 53(5):512-5. PubMed ID: 12722609
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of general practitioners' knowledge about diagnostic and therapeuthic management of erysipelas in the city of Marrakech].
Ihbibane F; Arsène NL; Adarmouch L; Amine M; Tassi N
Pan Afr Med J; 2018; 29():41. PubMed ID: 29875923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
